Alimera Sciences reported $-5955000 in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbvie ABBV:US $ 6567M 197M
Alimera Sciences ALIM:US $ -5.96M 1.82M
Applied Genetic Technologies AGTC:US $ -14.24M 4.87M
Insmed INSM:US $ -94236000 18.78M
Novartis NOVN:VX SF 3912M 230M
Ophthotech OPHT:US $ -34.54M 1.5M
Regeneron Pharmaceuticals REGN:US $ 1119.1M 1986M